Coronavirus
- Rheumatoid Arthritis
Could drugs derived from microalgae be effective against COVID-19?
Drugs effective against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) normally work by either reducing the rate at which…
Read More » - Rheumatoid Arthritis
Potential therapeutic targets of hydrogen for treatment of the COVID-19
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to the ongoing global pandemic.…
Read More » - Rheumatoid Arthritis
Scientists search for cause of mysterious covid-related inflammation in children
Like most other kids with covid, Dante and Michael DeMaino seemed to have no serious symptoms. Infected in mid-February, both…
Read More » - Rheumatoid Arthritis
Anti-rheumatic drug as a potential candidate for treating COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces inflammatory cytokine storms. But an FDA-approved anti-rheumatic drug, Auranofin, used to…
Read More » - Rheumatoid Arthritis
Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes
Researchers in the UK have conducted a large population-based study showing that people with immune-mediated inflammatory diseases (IMIDs) appear to…
Read More » - Rheumatoid Arthritis
Researchers study the role of low-density granulocytes in COVID-19
Information on granulocytes helps to understand mechanisms associated with covid-19 and other infectious diseases. Such information also promotes the development…
Read More » - Tuberculosis
COVID-19 Adds 95K Extra TB Deaths
They examined the impact of various reductions in social contacts and impacts on health services due to COVID-19. ‘This would…
Read More » - Rheumatoid Arthritis
Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases
A recent study published on the preprint server medRxiv* discusses the clinical characteristics and outcomes of patients with systemic autoimmune…
Read More »
